Information:
Fel:
ID
35324
Beskrivning
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01980888
Länk
https://clinicaltrials.gov/show/NCT01980888
Nyckelord
Versioner (1)
- 2019-02-28 2019-02-28 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
28 februari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Chronic Lymphocytic Leukemia NCT01980888
Eligibility Chronic Lymphocytic Leukemia NCT01980888
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Lymphocytic Leukemia NCT01980888
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Chronic Lymphocytic Leukemia
Item
documented diagnosis of b-cell cll, with diagnosis established according to international workshop on chronic lymphocytic leukemia (iwcll)
boolean
C0023434 (UMLS CUI [1])
Prior Therapy Absent Chronic Lymphocytic Leukemia | Exception Adrenal Cortex Hormones Disease complication
Item
no prior therapy for cll other than corticosteroids for disease complications
boolean
C1514463 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
C0544688 (UMLS CUI [2,3])
C0332197 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
C0544688 (UMLS CUI [2,3])
Chronic Lymphocytic Leukemia Treatment required for
Item
cll that warrants treatment
boolean
C0023434 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C0332121 (UMLS CUI [1,2])
Lymphadenopathy Measurable
Item
presence of measurable lymphadenopathy
boolean
C0497156 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of ≤ 2
boolean
C1520224 (UMLS CUI [1])
Chronic lymphocytic leukaemia transformation Aggressive lymphoma | Richter's syndrome
Item
known histological transformation from cll to an aggressive lymphoma (ie, richter transformation)
boolean
C1142081 (UMLS CUI [1,1])
C1332225 (UMLS CUI [1,2])
C0349631 (UMLS CUI [2])
C1332225 (UMLS CUI [1,2])
C0349631 (UMLS CUI [2])
MYELODYSPLASTIC SYNDROME
Item
known presence of myelodysplastic syndrome
boolean
C3463824 (UMLS CUI [1])
Systemic bacterial infection | Systemic mycosis | Systemic viral infection
Item
evidence of ongoing systemic bacterial, fungal, or viral infection at the time of randomization
boolean
C4285778 (UMLS CUI [1])
C0553576 (UMLS CUI [2])
C4285789 (UMLS CUI [3])
C0553576 (UMLS CUI [2])
C4285789 (UMLS CUI [3])
Injury of liver
Item
ongoing liver injury
boolean
C0160390 (UMLS CUI [1])
Non-infectious pneumonia
Item
history of non-infectious pneumonitis
boolean
C0264376 (UMLS CUI [1])
Inflammatory Bowel Disease
Item
ongoing inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
Bone Marrow Stem Cell Transplantation Allogeneic | Solid organ transplant
Item
history of prior allogeneic bone marrow progenitor cell or solid organ transplantation
boolean
C0842093 (UMLS CUI [1,1])
C1515895 (UMLS CUI [1,2])
C0730400 (UMLS CUI [2])
C1515895 (UMLS CUI [1,2])
C0730400 (UMLS CUI [2])
Therapeutic immunosuppression | Exception Adrenal Cortex Hormones
Item
ongoing immunosuppressive therapy other than corticosteroids
boolean
C0021079 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
Study Subject Participation Status | Investigational New Drugs
Item
received last dose of study drug on another therapeutic clinical trial within 30 days prior to randomization
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])